New cholesterol methods needed in wake of failed drugs, heart researchers say
April 03, 2016 at 09:00 AM EDT
April 3 (Reuters) - New ways of controlling cholesterol, including possibly directly injecting "good" HDL cholesterol into patients, need to be studied following the failure of promising treatments from Eli Lilly, Pfizer Inc and Roche Holding AG, according to top heart researchers.